R&D in UKsPharmaceuticalCompaniesGroup #3:Ahmed Abuiliazeed Diaa el BagouryOsama Hagag Mohamed Tarek
Presentation Structure:1. Overview.2. UK Pharma Now and Then.3. Problem Definition.4. Research Methodology.5. Challenges a...
Overview● Competition with global market fueled theneed for more R&D activities and innovation.● R&D staff size, and R&D e...
UK Pharma Industry Now:● Economic value of the industry
UK Pharma Industry Now:● R&D expenditures by sector
History● Number of new chemical entities per year
History● Local vs Global Market
Problem Definition● UK falling behind competitors in thepharmaceutical industry○ Emerging economies○ Developed economies○ ...
Problem Definition● Companies with more focus on R&D moresuccessful?● Relation between innovation - company size.● How to ...
Research Methodology● The hypothesis of the research was basedon finding relationship between research andinnovation.● Cla...
Data Resources & Classification1. Number of patents taken out of the company.2. Number of scientific papers published by i...
Data Resources & ClassificationThe data was collected from:● 6 pharmaceutical companies● Publications by the Department of...
Additional Resources● Interviews with the R&D departments headsof the top 10 Pharmaceutical companies inUK.● survey with 1...
Research Challenges& Solutions● Company merges moved archives around.● Difficult to get data from companies.● Some of the ...
Lessons Learned● Keep an eye on the availability of data onthe subject, to not waste time or draw falseconclusions.● Raw d...
References :1. Research and development in the UK pharmaceutical industry in the1960s.2. The UK Pharmaceutical Industry: C...
Thanks
Upcoming SlideShare
Loading in...5
×

UK Pharma R&D

420
-1

Published on

R&D in UK's Pharma Companies.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
420
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
9
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

UK Pharma R&D

  1. 1. R&D in UKsPharmaceuticalCompaniesGroup #3:Ahmed Abuiliazeed Diaa el BagouryOsama Hagag Mohamed Tarek
  2. 2. Presentation Structure:1. Overview.2. UK Pharma Now and Then.3. Problem Definition.4. Research Methodology.5. Challenges and Solutions
  3. 3. Overview● Competition with global market fueled theneed for more R&D activities and innovation.● R&D staff size, and R&D expenditures leadto more innovation in the company?● Level of innovation compared to the relativesize of the corporation.● Data sources:○ Loss of easy access to data due to large companymergers.○ Power of public data records
  4. 4. UK Pharma Industry Now:● Economic value of the industry
  5. 5. UK Pharma Industry Now:● R&D expenditures by sector
  6. 6. History● Number of new chemical entities per year
  7. 7. History● Local vs Global Market
  8. 8. Problem Definition● UK falling behind competitors in thepharmaceutical industry○ Emerging economies○ Developed economies○ Lack of government investment● Solutions:○ Change business model○ Actions against counterfeit medicine○ Understanding global competition○ Preventive medicine through focus on R&D
  9. 9. Problem Definition● Companies with more focus on R&D moresuccessful?● Relation between innovation - company size.● How to quantify innovation?○ Papers○ Patents○ New drugs.● Company size measured through R&D○ R&D expenditure○ Number of researchers.
  10. 10. Research Methodology● The hypothesis of the research was basedon finding relationship between research andinnovation.● Claire decided to consider R&D expenditure,Number of scientists employed as researchindicators.● She also considered number of patents,research papers and new drugs produced asindicators for new innovations.
  11. 11. Data Resources & Classification1. Number of patents taken out of the company.2. Number of scientific papers published by its scientists.3. Number of drugs theyve launched on the marketbetween 1960 and 1969.4. Companies R&D expenditure.5. Number of scientists employed in R&D departments.
  12. 12. Data Resources & ClassificationThe data was collected from:● 6 pharmaceutical companies● Publications by the Department of trade, Department ofHealth.● Patent office● National Economic Development Office.● Reports from stockbrokers● Association of British Pharmaceutical Industry (ABPI).● Publications and good quality journalist Reports on theIndustry.
  13. 13. Additional Resources● Interviews with the R&D departments headsof the top 10 Pharmaceutical companies inUK.● survey with 1000 participants from thepharmaceutical industry.
  14. 14. Research Challenges& Solutions● Company merges moved archives around.● Difficult to get data from companies.● Some of the public data available was undera 30-year closure rule.● Public data sometimes not comprehensiveenough.Solution:● Extract information from ministry of healthcommittees.● Wait until data becomes available eventually
  15. 15. Lessons Learned● Keep an eye on the availability of data onthe subject, to not waste time or draw falseconclusions.● Raw data from the primary sources would bemost accurate.
  16. 16. References :1. Research and development in the UK pharmaceutical industry in the1960s.2. The UK Pharmaceutical Industry: Current Challenges and FutureSolutions3. Employment in the pharmaceutical industry in the UK4. Pharmaceutical innovation by the seven UK-owned pharmaceuticalcompanies (1964-1985)
  17. 17. Thanks
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×